Jaime Prada

Check out Orsini’s latest white paper, exploring the dynamic world of classical hematology. From hemophilia to sickle cell disease, we showcase groundbreaking hematology advancements, uncover trends and hurdles in treatment, and spotlight key payor considerations. Download the white paper now! https://hubs.la/Q02tY91v0 #ClassicalHematology #SpecialtyPharmacy #PatientCare #Hemophilia #SickleCellDisease

2

As we move past the 4th of July holiday, it's crucial to pause for a mid-year review of trends shaping our biopharma industry: Growth of Advanced Modalities: Biopharma companies are heavily investing in cutting-edge treatments like gene therapies and RNA-based therapeutics, paving the way for addressing previously untreatable diseases. Global Pricing Pressure: Pricing negotiations remain complex as governments, payers, and patients demand transparency and affordability, challenging companies to balance innovation and access to life-saving therapies. Evolving Commercialization Models: The shift towards direct-to-consumer approaches, digital marketing, and patient-centric strategies is transforming traditional commercialization models, accelerated by telemedicine and virtual engagement trends from the recent pandemic. Focus on Patient Diagnosis and Biomarkers: Biomarker-driven endpoints in clinical trials are on the rise, optimizing patient outcomes through tailored treatments and minimizing adverse effects. Evolving Financing Landscape: Biopharma firms are diversifying financing sources through partnerships, licensing deals, and public offerings, with special purpose acquisition companies (SPACs) influencing funding strategies. The biopharma industry's dynamic nature requires adaptable partners. Discover how WEP Clinical can support your success amidst these industry shifts at wepclinical.com. Let's connect and discuss how we can excel together in these changing times.

12

My favorite days at work are those when I get to connect with patients – to hear their stories, witness their resilience, and on the best days, learn how one of our therapies is helping them. I’m constantly inspired by the courage of people living with Crohn’s disease and ulcerative colitis – and the families who support them. Invisible but powerful, these autoimmune diseases impact every part of daily life. That’s why my team at Johnson & Johnson Innovative Medicine is committed to helping more patients achieve remission.       This Crohn’s & Colitis Awareness Week, learn more about inflammatory bowel disease: https://bit.ly/3VkrUt7 #JNJImmunology #MyCompany 

80

2 Comments

This content is intended for U.S. audiences only. The countdown to Chicago is on, as we gear up for #ASCO24 in less than two weeks! For the first time, @AstraZeneca will headline not one, but TWO back-to-back plenary sessions in LUNG as well as a late-breaking study in BREAST. Our team is focused on treating cancers at earlier stages and across subtypes while advancing medicines and combination therapies that attack the disease from all angles, evidenced by our strong, diverse research to be presented in Chicago. Behind every data point is a patient, who deserves a personalised therapy that will give them a longer and healthier life. For each one, we’re pushing the boundaries of science, and I can’t wait to highlight our research advances in the coming weeks. Stay tuned! 🔬 For a more detailed preview of our #ASCO24 data presentations, please see our press release https://lnkd.in/ehH7tqFc #CancerResearch #oncology #MedicalAdvancements

224

3 Comments

Great minds think alike. And sometimes, they work together. 😉 Excited to share some of Teva's recent partnerships to innovation: 💊 Receiving funding support of up to $125 million from Royalty Pharma to advance treatments for schizophrenia 🤝 Collaborating with Sanofi to develop new therapies for patients with inflammatory bowel disease 💪 Working with Alvotech to develop biosimilar treatments for rheumatoid arthritis and other chronic conditions 💻 Exploring computational biology and AI with Biolojic Design to create new therapies for dermatitis and asthma 🚀 Co-founding AION Labs with industry leaders to use AI and big data to speed up the discovery of new drugs 🎓 Building over 30 collaborations with research institutions to work with leading labs around the world 🔬 Conducting early biomarker research with MetaSight Diagnostics to develop liquid biopsy diagnostics for the early detection of chronic and acute diseases We’re proud to be part of the strategic partnerships for scientific breakthroughs. More here > https://lnkd.in/e-u-9Knm #Tevapharm #TevaCareers #WeAreAllInForBetterHealth #PivotToGrowth

4

Having a large expert pool to form your DMC means more effective problem solving. At Advarra, our global network of 1,500+ experts helps us efficiently address unexpected challenges during the trial. Read our blog to find out more. #clinicalresearch #clinicaltrials

11

Join us on Wednesday, July 24 at 8:30 a.m. EDT for Mind the Gap: The Cost of Mental Health Disparities, a live discussion hosted by The Hill and sponsored by Otsuka. One in five U.S. adults live with a mental illness, yet access to treatment remains a challenge. This is especially true for lower-income individuals and minority populations who bear a disproportionate burden of both mental health and chronic conditions. According to the National Alliance on Mental Illness (NAMI), Non-Hispanic White adults (52%) are more than twice as likely to receive treatment for a mental illness compared to Asian Americans (25%). Those numbers increase modestly among the Hispanic or Latino (36%) and Black or African American (39%). What barriers prevent racial and ethnic minority groups, as well as other marginalized, rural, and under-resourced populations, from accessing treatment? What are the unique mental health needs of racially and ethnically diverse communities? What is the economic cost of not investing in mental health services, treatments, and programs? How can we change the conversation around minority mental health to reduce stigma and encourage more integrated, equitable care? In honor of Minority Mental Health Awareness Month, the Hill will bring together lawmakers, mental health experts and advocates to discuss these questions and more as they discuss the findings of the Meharry School of Global Health’s 2024 study, “The Projected Costs and Economic Impact of Mental Health Inequities in the United States.” Register for the event: https://bit.ly/4bzELN9 https://dy.si/m77o8

9

FDA approves Biosimilar Imuldosa, reference product Stelara Oct. 11, 2024 Stelara is one of the highest-grossing biologics in the US, generating $10.86 billion globally in 2023. Accord BioPharma's Imuldosa ustekinumab-srlf is indicated for the treatment of autoimmune diseases such as plaque psoriasis, psoriatic arthritis, Crohn disease, and ulcerative colitis. Ustekinumab is a humanized immunoglobulin G1k (IgG1k) monoclonal antibody. It is Interleukin (IL)–12 and IL-23 antagonist Available as SC Inj. in 45 mg/0.5 mL and 90 mg/mL PFS or via IV infusion in a 130 mg/26 mL (5 mg/mL) single-dose vial. #reseaechanddevelopment #innovation #biologics #biosimilar #biotechnology #healthcare #lifesciences #fdaapproval #monoclonalantibody #crohndisease #ulcerativecolitis #plaquepsoriasis #psoriaticarthritis #autoimmunedisorder

14

1 Comment

International Friendship Day: A Celebration of Bonds Beyond Borders International Friendship Day is celebrated around the world to honor the bonds that go beyond cultural, geographic, and ideological boundaries. The idea of a day dedicated to friendship can be traced back to various ancient cultures where friends were valued as pillars of support. However, the modern inception of International Friendship Day is credited to Joyce Hall, the founder of Hallmark cards, who proposed the idea in 1930. But in india Friendship is from Krishna and Sudama era On International Friendship Day, people commonly exchange gifts, cards, and flowers with their friends to show appreciation. Various cultures have unique ways to celebrate Friendship transcends superficial differences, binding people through shared experiences, mutual respect, and unyielding support. International Friendship Day serves as a reminder to cherish and nurture these relationships. Friendship is not just about personal relationships but also about fostering peace and understanding among nations. Through educational and community events, schools, NGOs, and various organizations emphasize the importance of cooperation and brotherhood. International Friendship Day is more than just an occasion; it’s a celebration of the very essence of human connection. Whether it's through grand gestures or simple acts of kindness, this day reminds us that friends are invaluable treasures, binding us in a beautiful web of shared memories and mutual respect.

135

4 Comments

"IQVIA estimates that the dearth of a Humira (adalimumab) biosimilars last year cost patients and employers cumulatively $6 billion." #Biosimilars #Adalimumab like #Hulio from #BioconBiologics can provide #affordable #access to #patients and save billions for the Government. #Biosimilars are the way forward for affordable biologics therapy. Read the article: US Specific "The biosimilar Hulio was offered last year at a WAC of $498 for a month's supply, versus $3,461 for Humira, according to a Samsung Bioepis biosimilar report. Still, the vast majority of prescriptions filled in 2023 were for the Humira originator product, prompting market research group IQVIA to conclude that “maintaining patients on Humira comes at a cost of up to about $6 billion per year for patients and employers, compared to a full transition to adalimumab biosimilars.” Biocon Biologics Matt Erick Joshua Salsi https://lnkd.in/gN74FShF

33

Each year WEST - Women in the Enterprise of Science and Technology selects an annual theme. This year's theme is: Grit, Growth, Gratitude. Read more to dive into what that means to WEST. https://hubs.ly/Q02LvGnD0

4

Most of us don’t like change. So, to increase the chances of success with biosimilar adoption we make it easy for providers and their patients, using proactive outreach to boost their confidence in the covered biosimilars, and ensure a frictionless transition. Listen to Emily Pefanis, PharmD, in the latest #AskCaremark segment. #TeamCVS

1

FDA Approves Attruby for Heart Disorder Caused by Transthyretin-Mediated Amyloidosis (ATTR-CM) Nov 25, 2024 ATTR-CM is a rare and serious disease that affects the heart muscle. In patients with ATTR-CM, there is a build-up of protein deposits in the heart, causing the walls of the heart to become stiff, and making the left ventricle unable to properly relax and fill with blood (called cardiomyopathy). As the condition progresses, the heart can become unable to pump blood out adequately, causing heart failure. BridgeBio’s Attruby (acoramidis), is a Near Complete TTR Stabilizer (≥90%). Attruby was designed to mimic a naturally occurring “rescue mutation” of the TTR gene (T119M) that targets the root cause of ATTR-CM, destabilization of the native TTR tetramer. Through near-complete TTR stabilization, Attruby has been shown to preserve the native function of TTR as a transport protein of thyroxine and vitamin A and to demonstrate benefit on cardiovascular outcomes. #researchanddevelopment #innovation #heartdisorder #healthcare #qol #fdaapproval #lifesciences #raredisease

24

1 Comment

Love moves the world. When death halts, chaos ensues; love transforms death herself, revealing humanity's need for compassion, mortality, and purpose. A great book (my friend during my last trip to Zurich) from one of my favorites writers such José Saramago. The book is "Le Intermittenze della Morte" (Death with Interruptions in English). The book parallels leadership by highlighting the importance of embracing impermanence and adapting to change. Death's vulnerability and choice to act out of love symbolize authentic leadership—balancing authority with empathy. The value of love transcends control, showing that compassion and connection are vital in guiding others and confronting life's inevitabilities.

53

2 Comments

Proud to share an exciting milestone in our journey to advance care for patients living with #UlcerativeColitis! Today, Johnson & Johnson Innovative Medicine submitted an application to the FDA seeking approval for a subcutaneous induction regimen – a first-of-its-kind innovation among IL-23 inhibitors. This submission marks a significant step forward in offering an option for patients managing this chronic and often unpredictable condition. It’s a testament to our relentless commitment to transforming the treatment landscape in #IBD and beyond. Grateful for the collaboration, persistence, and dedication of our teams across #Immunology, R&D, and beyond who made this possible. Read our announcement here: https://bit.ly/494siS5 #MyCompany #JNJImmunology #UlcerativeColitis #IBD

154

3 Comments

Download this eGuide to see a breakdown of our +1.4 million compound library, and learn how we curate, QC and design strategic screening sets: https://okt.to/msJfwH

13

What a great day! Global and local colleagues came together to discuss AI and the future of the sales rep. Two things are clear, AI can help marketers make better strategic decisions and the sales rep is here to stay! Watch this space for more updates from the meeting!

9